ACUTE MESENTERIC ISCHAEMIA: THE NEED TO BE AWARE
Dr. Meheshinder Singh
SUMMARY
Acute mesenteric ischaemia is a life threatening surgical condition which
carries & high mortality. A delay in diagnosis combined with the premorbid
condition of the patient is usually responsible for its poor outcome. This
review article highlights the importance of awareness of this condition and
discusses the aetiopathogenesis, diagnosis and various modalities of surgical
and non surgical management.
Key words: Acute mesenteric ischaemia (AMI), superior mesenteric artery (SMA).
INTRODUCTION
Acute mesenteric ischaemia, though a relatively rare condition, poses a particular
surgical challenge because failure to diagnose it early results in death.
It refers to a threatened or established ischaemic necrosis of the major part
of the bowel and tends to occur in patients of either sex predominantly those
above 50 years of age. The mortality from acute mesenteric ischaemia has not
changed during the past two decades and unless we are aware of its entity
and in the absence of an accurate diagnostic test, it is unlikely to do so.
AETIOLOGY
Acute mesenteric ischaemia (AMI) can be a consequence of 4 basic conditions
- embolization, thrombosis of pre existing occlusive disease, non-occlusive
mesenteric ischaemia, and mesenteric venous thrombosis. Mesenteric arterial
emboli account for 30-50% of cases of AMI. They most commonly arise from a
mural thrombus in an infarcted left ventricle (Figure 1) or a clot in patients
with atrial fibrillation. Emboli may also arise from atheromatous plaques
in the aorta (Table 1). The embolus lodges in the Superior Mesenteric Artery
(SMA) a few centimeters from its origin and usually spares the middle colic
artery and proximal jejunal branches thereby causing an infarction that is
less then that seen following SMA thrombosis. Thrombosis of SMA accounts for
20-25% of cases of AMI. It occurs in an artery already diseased by atheroma
and commonly follows a sudden decrease in cardiac output such as in congestive
cardiac failure or after a myocardial infarction. Less commonly, hypercoagulable
states and certain vasculitic conditions (Table 2) may. precipitate thrombosis.
The extent of infarction is much more severe in thrombosis as the proximal
part of SMA is usually occluded so that the entire small bowel distal to the
ligament of Treitz and the proximal two thirds of the transverse colon are
affected. Non-occlusive mesenteric ischaemia represents 15-20% of cases of
AMI. It results from inadequate arterial blood flow as a consequence of spasm
of mesenteric arteries usually with a background of severe systemic illness
or cardiac failure and should always be suspected in a critically ill patient.
Figure 1: ECHO showing a mural thrombus within the left ventricle
Mesenteric venous thrombosis is more common than is generally recognized. It accounts for 10-15% cases of AMI. Venous thrombosis does not always progress to bowel infarction. When thrombosis of only the large veins occur, collateral drainage is often adequate to prevent tissue necrosis. It is only when the small veins and venules of the bowel wall are involved that infarction occurs. Predisposing conditions include portal hypertension, trauma, hypercoaguable states due to factor deficiencies, prolonged use of oral contraceptives or malignancy, and less commonly inflammatory conditions such as diverticulitis.
Table 1: Sources of arterial emboli
| Cardiac |
Post acute myacardial infarction Atrial fibrillation -chronic and paroxysmal Ventricular aneurysm Endocarditis - infectious Cardiomyopathy Prosthetic heart valves Atrial myxoma |
| Non-cardiac |
Aortic aneurysm Aortic atherosclerosis |
Table 2: Factors causing acute thrombosis in an already diseased vessel
| Acquired |
Low output states
Vasculitic disorders e.g. polyarteritis nodosa |
||||
| Inherited |
Antithrombin 3 deficiency Protein c deficiency Protein s deficiency Dysfibrinogenemia Dysplasminogenemia |
PATHOGENESIS
The consequences of mesenteric vascular occlusion depend upon the vessel involved,
the level of occlusion, status of other visceral vessels, the development
of collaterals, presence of contributing diseases like cardiac failure and
the establishment of reperfusion. Tissue injury results from event; related
to ischaemia or by the return of blood flow, either spontaneous or as a result
of treatment (reperfusion injury). Complete interruption of oxygen supply
to the intestine produces necrosis first at the tips of the villi. Mucosal
slough begins within 3 hours after onset of ischaemia and ulceration and bleeding
soon become extensive. Full thickness infarction of bowel wall occurs as early
as 6 hours. Haemorrhage into the lumen, accumulation of bloody abdominal fluids,
perforation, bacterial translocation and death from sepsis and multi organ
system failure are the end result. There is increasing recognition of the
importance of reperfusion injury. Reperfusion of the affected segment of bowel
either from spontaneous events, lysis of clot by medical therapy or arterial
reconstruction converts the enzyme xanthinedehydrogenase to xanthine oxidase.
This results in the release of oxygen free-radicals (OFR) which destabilize
cell membranes, disrupt the mucosal barrier and flood the systemic circulation
with mediators of damage to other organs leading to multi system organ failure.
CLINICAL FEATURES
Acute abdominal pain is the initial symptom in 85% of patients with AMI. Pain
is severe, poorly localised and the diagnosis should be considered if the
pain is unresponsive to narcotic analgesia. The rate of progression is variable
but usually is accompanied by abdominal distension, vomiting and passage of
mucus and bloody stools. Physical findings in early stages are minimal, resulting
in the dictum that AMI is characterised by "pain that is out of proportion
to physical findings". Later in the course, pyrexia, abdominal distension,
tenderness and guarding occurs. Generalized peritonitis and eventually shock
develops if treatment is further delayed. The minority of cases of AMI caused
by venous obstruction or non-occlusive mesenteric ischaemia will follow a
similar course but at a slower and more variable rate.
DISCUSSION
Acute mesenteric ischaemia is an abdominal catastrophe that carries high morbidity
and mortality rates. Current diagnostic methods lack sensitivity and specificity
and do not provide adequate information regarding viability of the afffected
bowel. Leucocytosis and elevatad serum lactate levels are common1,2. The
other laboratory investigations are of little value. Elevated serum amylase
is non-specific. Metabolic acidosis occurs only after advanced ischaemia.
Plain abdominal X-rays are also non-specific. An ileus pattern, diffuse distension
with air-fluid levels, evidence of bowel wall oedema, or even gas in the bowel
wall or within mesenteric or portal veins are some of the findings that may
allow a presumptive diagnosis of mesenteric ischaemia. CT scan is not a specific
diagnostic study of choice but it is often used to rule out other pathology.
However, it exhibits sensitivity and specificity that is found to be higher
than conventional radiography. Duplex ultrasonography3 in experienced hands
can be accurate in assessing flow in proximal visceral arteries as well as
superior mesenteric and portal veins. Gaseous abdominal distension can cause
some amount of technical difficulty. Other forms of non-invasive detection
include SQUID4 (superconducting quantum interference devices) which detects
basic electrical rhythm (BER) by measuring the magnetic fields generated by
the electrical activity of the smooth muscle of the small bowel. SQUID has
been shown to have a high degree of sensitivity and specificity in detecting
bowel ischaemia in animal models. The most important diagnostic modality is
angiography5 It confirms the clinical diagnosis and aids in planning specific
therapy. However, some argue that it is time consuming, delays treatment and
does not provide information that cannot be determined at laparotomy. Due
to the short ischaemic tolerance time of the intestine, diagnostic and therapeutic
decisions have to be made under extreme time pressure. The principles of treatment
are adequate rehydration, broad-spectrum antibiotics and early surgical intervention.
Various studies have shown an improved survival following early diagnosis
and aggressive management. Surgical techniques involve revascularisation techniques
and/or bowel resection. At laparatomy, the appearance of the bowel wall may
vary from pallor to haemorrhagic infarction. Established infarcted bowel should
be resected and a second look procedure planed 24-48 hours later. Revascularisation
techniques include isolated embolectomy, thromboendarterectomy, bypass techniques
and intraarterial thrombolysis6-10. The main difficulty at operation is
to predict intestinal recovery and to accurately assess amount of bowel that
needs to be resected. Clinical assessment relies on color, contractility and
capillary bleeding, all of which are insensitive11. Several methods have
been described which can help judge viability. Doppler ultrasonic flowmeter
may be helpful but results with the laser Doppler system proves to be promising11.
Another technique known as fluorescein dye technique11 is still under study.
A decision to perform a second look operation is made at the time of initial
laparatomy. Since there are no certain predictive criteria for the progression
of ischaemia, and not all patients are reoperated for a second look, some
patients will undergo unnecessary surgical and anaestheological procedure
(negative second look). For this reason a laparoscopic second look is done
routinely in some centres11-13 as a substitute to the standard laparotomy.
CONCLUSION
Acute mesenteric ischaemia is a life threatening vascular emergency which
has high mortality rates. The population is usually elderly with coexistent
medical illnesses and the diagnosis often delayed. Multisystem organ failure
is a common postoperative sequlae. Results can be optimised by prompt diagnosis,
adequate resuscitation, effective revascularisation and meticulous postoperative
care.
REFERENCES
1. Lange H et al. Usefulness of plasma lactate concentration
In diagnosis of acute
abdominal disease Eur J. Surg 1994, Jun; 160 (6-7), 381-4
2. Murray MJ, Gonze MD, Nowak LR, Cobb CF. Serum D(-) lactate levels as an
aid to diagnosing acute intestinal ischaemia. Am J Surg 1994, Jun; 167(6);575-8
3. Danse EM, Van Beers BE, Goffette P, Dardenne AN, Laterre PF. Pringot J.
Acute
intestinal ischaemia due to occIusion of superior mesenteric arrary: detection
with Doppler sonography. J Ultrasound Med 1996 Apr; 15(4); 323-6
4. Seidil SA. Bradshaw LA, Ladipo JK, Wikso JP Jr, Richards WO. Non invasive
detection of ischaemic bowel. J Vasc Surg 1999 Aug; 30(2); 309-319.
5. Lock C, Schiolnierkh J. Non occlusive mesenteric ischaemia. Hepatogastroenterology
1995 Jul; 42(3); 234-9.
6. Christensen MC, Lorentzen JE, Schroeder TV. Revascularisation of
atherosclerotic mesenteric arteries. Eur J Vasc Surg 1994 May; 8(3); 297-302
7. McBride KD, Caines PA. Thrombolysis of a partially occluding superior mesenteric
artery thromboembolus by infusion of streptokinase. Cardiovasc Intervent Radiol
1994 May 17(3); 164-6.
8. Gentile AT, Moneta GL, Taylor LM Jr, Park TC, McConnell DB, Porter JM.
Isolated bypass to the superior mesenteric artery for intestinal ischaemia.
Arch Surg 1994 Sept;129(9); 926-31.
9. Bradbury AW, Brittenden J, McBride K, Ruckley CV. Mesenteric ischaemia:
rnultidisciplinary approach. Br J Surg 1995 Nov; 82(11):1446-59.
10. An aggressive approach to acute superior mesenteric arterial ischaemia.
PA Grace, M Da Costa, A. Qureshi, S Sheehan. P Burke, D Bouchier-Hayes Eur
J Vasc Surg 1993; 7:731-732.
11. Ballard JL, Stone WM, Hallett JW, Pairolero PC, Cherry KJ. A critical
analysis of adjuvant techniques used to assess bowel viability in acute mesenteric
ischaemia. Am Surg. 1993; 59(5):309-11.
12. Sackier JM. Second look laproscopy in management of acute mesenteric ischaemia.
Br J Surg 1994; 81(10);154-6.
13. Nassar A. Second look laproscopy in management of acute mesenteric ischaemia.
Br J Surg 1994; 81(7); 108-13.


